Cargando…
The First-in-Human Whole-Body Dynamic Pharmacokinetics Study of Aptamer
Serving as targeting ligands, aptamers have shown promise in precision medicine. However, the lack of knowledge of the biosafety and metabolism patterns in the human body largely impeded aptamers’ clinical translation. To bridge this gap, here we report the first-in-human pharmacokinetics study of p...
Autores principales: | Ding, Ding, Zhao, Haitao, Wei, Dali, Yang, Qinglai, Yang, Cai, Wang, Ruowen, Chen, Yumei, Li, Lianghua, An, Shuxian, Xia, Qian, Huang, Gang, Liu, Jianjun, Xiao, Zeyu, Tan, Weihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AAAS
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202413/ https://www.ncbi.nlm.nih.gov/pubmed/37223462 http://dx.doi.org/10.34133/research.0126 |
Ejemplares similares
-
Using modified aptamers for site specific protein–aptamer conjugations
por: Wang, Ruowen, et al.
Publicado: (2016) -
Automated
Modular Synthesis of Aptamer–Drug
Conjugates for Targeted Drug Delivery
por: Wang, RuoWen, et al.
Publicado: (2014) -
Site-Specific Radioiodination of Oligonucleotides with a Phenolic Element in a Programmable Approach
por: Zhao, Haitao, et al.
Publicado: (2022) -
Programmable manipulation of oligonucleotide–albumin interaction for elongated circulation time
por: Yang, Cai, et al.
Publicado: (2022) -
Radiosynthesis and First Preclinical Evaluation of the Novel (11)C-Labeled FAP Inhibitor (11)C-FAPI: A Comparative Study of (11)C-FAPIs and ((68)Ga) Ga-DOTA-FAPI-04 in a High–FAP-Expression Mouse Model
por: Wang, Cheng, et al.
Publicado: (2022)